FDA Approves Medtronic’s Next-Gen Recharge-Free Spinal Cord Stimulation Platform
Medtronic has received U.S. FDA approval for Vanta, a high-performance recharge-free implantable neurostimulator with a device life that can be optimized up to 11 years.